FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4902911000001100: Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26902901000001111 Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26903001000001119 Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Benz) true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Is a Dipotassium clorazepate 15mg capsules 20 capsule true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Is pack of Tranxene 15mg capsules (Boehringer Ingelheim Ltd) false Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Has active ingredient Dipotassium clorazepate false Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Has AMP Tranxene 15mg capsules (Boehringer Ingelheim Ltd) true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Has specific active ingredient Dipotassium clorazepate true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Tranxene 15mg capsules (Boehringer Ingelheim Ltd) 20 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start